Top story

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Read full story

F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs

The New York Times - Drugs & Pharmaceuticals
By Rebecca Robbins - Wed, 29 Oct 2025
Read more

Testosterone Is Giving Women Back Their Sex Drive but Risks Side Effects

The New York Times - Drugs & Pharmaceuticals
By Susan Dominus - Wed, 22 Oct 2025
Read more

Cardiovascular Benefits of Wegovy Extend Beyond Weight Loss, Study Shows

The New York Times - Drugs & Pharmaceuticals
By Dani Blum - Wed, 22 Oct 2025
Read more

Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenol

The New York Times - Drugs & Pharmaceuticals
By Rebecca Robbins and Azeen Ghorayshi - Wed, 24 Sep 2025
Read more

FDA Approves Updated Covid Vaccines With New Restrictions

The New York Times - Drugs & Pharmaceuticals
By Christina Jewett and Jacey Fortin - Wed, 27 Aug 2025
Read more

Top F.D.A. Official Resigns Under Pressure

The New York Times - Drugs & Pharmaceuticals
By Christina Jewett - Wed, 30 Jul 2025
Read more

A Pill for Sleep Apnea Could Be on the Horizon

The New York Times - Drugs & Pharmaceuticals
By Caroline Hopkins Legaspi - Wed, 23 Jul 2025
Read more

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The New York Times - Drugs & Pharmaceuticals
By Stephanie Nolen - Wed, 23 Jul 2025
Read more

What’s Best for My Pain: Tylenol or Advil?

The New York Times - Drugs & Pharmaceuticals
By Erica Sweeney - Wed, 28 May 2025
Read more